| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |